胺碘酮联合替米沙坦治疗120例阵发性房颤患者临床疗效观察
 |
| 第1页 |
参见附件。
摘要：目的观察胺碘酮、替米沙坦治疗阵发性房颤(PAF)的临床效果。方法选取我院2011年9月~2013年8月收治的120例PAF患者。对照组仅口服胺碘酮，研究组则加用替米沙坦。结果治疗2年后，两组患者的房颤发作频次均较治疗前显著减少，房颤持续的时间显著缩短，LVEF均有所增加。上述指标行组间比较，研究组改善的程度较对照组更加明显。两者具有统计学意义(P<0.05)。结论胺碘酮、替米沙坦联用治疗PAF能够有效减少房颤的发生，同时提高LVEF，抑制LAD增加。
关键词：胺碘酮；替米沙坦；LVEF；房颤次数
Clinical Efficacy in Patients with Paroxysmal Atrial Fibrillation was Observed 120 Cases of Amiodarone Therapy with Telmisartan
MA Yong-qiang,MAO Jian-hua,QIAN Jun
(Department of Cardiology,The Central Hospital of Ma'anshan City,Ma'anshan 243000,Anhui,China)
Abstract：ObjectiveTo observe amiodarone, telmisartan treatment of paroxysmal atrial fibrillation (PAF) clinical results. Methods2011.9-2013.8 admitted to our hospital 120 cases of PAF patients. Only oral amiodarone group, the study group is added with telmisartan. ResultsAfter 2 years of treatment, both groups of patients with atrial fibrillation frequency than before treatment significantly reduced the duration of atrial fibrillation was significantly shortened, LVEF had increased. Among these indicators line group, the degree of improvement in the study group was significantly more than the control group ......
您现在查看是摘要介绍页，详见PDF附件。